Cardiac Inflammation Research Group
1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Cardiac ATP production and contractility are favorably regulated by short-term S100A9 blockade after myocardial infarction
2025) In Journal of Advanced Research(
- Contribution to journal › Article
-
Mark
Deferral of left main coronary artery revascularization via IVUS or coronary physiology - Long-term outcomes from the SWEDEHEART registry
(
- Contribution to journal › Article
-
Mark
Long-Term Clinical Outcomes After IFR- vs FFR-Guided Coronary Revascularization : Insights From the SWEDEHEART National Registry
(
- Contribution to journal › Article
-
Mark
Calprotectin as a sepsis diagnostic marker in critical care : a retrospective observational study
(
- Contribution to journal › Article
-
Mark
Plasma proteomic and metabolomic profiling of coronary and carotid atherosclerosis in the SCAPIS study - differences and similarities
2025) In Cardiovascular Research(
- Contribution to journal › Article
- 2024
-
Mark
Special Issue “COVID-19 Coagulopathy: Advances on Pathophysiology and Therapies”
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
(
- Contribution to journal › Article
-
Mark
Short-term S100A8/A9 Blockade Promotes Cardiac Neovascularization after Myocardial Infarction
2024) In Journal of Cardiovascular Translational Research(
- Contribution to journal › Article
-
Mark
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. Reply
(
- Contribution to journal › Letter
-
Mark
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-Aged individuals
(
- Contribution to journal › Article